Boyle Kevin S. Sr.
SEC CIK 1880600 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TCRT | Alaunos Therapeutics, Inc. | CEO, Dir | 798.2K | $14.0K | $9,522 | 4 | 2021-08-30 | 2023-09-01 |
Most active insiders at TCRT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Jerman Michael Allen | Dir | — | — |
| 2 | Weis Holger | CEO | — | — |
| 3 | Vieser Jaime | Dir | — | — |
| 4 | Postma Robert W | Dir | — | — |
Boyle Kevin S. Sr. made no open-market trades at TCRT in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2023-09-05 | 2023-09-01 | TCRT | Alaunos Therapeutics, Inc. | Boyle Kevin S. Sr. | CEO, Dir | S - Sale | $0.14 | -68.0K | 798.2K | -8% | -$9,522 |
| 2022-09-01 | 2022-08-30 | TCRT | Alaunos Therapeutics, Inc. | Boyle Kevin S. Sr. | CEO, Dir | F - Tax | $2.41 | -18.8K | 866.2K | -2% | -$45.2K | |
| M | 2021-11-17 | 2021-11-16+ | TCRT | Alaunos Therapeutics, Inc. | Boyle Kevin S. Sr. | CEO, Dir | P - Purchase | $1.40 | +10.0K | 885.0K | +1% | +$14.0K |
| D | 2021-08-31 | 2021-08-30 | TCRT | Alaunos Therapeutics, Inc. | Boyle Kevin S. Sr. | CEO, Dir | A - Grant | $0.00 | +875.0K | 875.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations